%
2006 2007 Change
Net patient service revenue $79,868 $79,739 -0.2%
Expenses:
Salaries, wages and benefits 36,765 38,521 4.8%
Supplies 7,281 8,509 16.9%
Rent 4,541 5,953 31.1%
Other operating expense 17,087 16,970 -0.7%
Provision for doubtful accounts 3,385 453 -86.6%
Depreciation and amortization 3,054 2,570 -15.8%
Goodwill impairment charges 19,000 35,000 84.2%
Long-lived asset impairment charges 945 - NM
Interest expense, net 8,234 9,445 14.7%
100,292 117,421 17.1%
Operating loss (20,424) (37,682) 84.5%
Equity in loss of joint venture - (246) NM
Loss before income taxes (20,424) (37,928) 85.7%
Provision for (benefit from) income
taxes (802) 2,729 -440.3%
Net loss $(19,622) $(40,657) 107.2%
Reconciliation to Credit Agreement
EBITDA:
Operating loss - per above $(20,424) $(37,682)
Adjusted for:
Interest expense, net 8,234 9,445
Depreciation and amortization 3,054 2,570
Goodwill impairment charges 19,000 35,000
Stock compensation expense 164 169
Cost saving initiatives - 320
Hospital closure/reloca
'/>"/>
SOURCE LifeCare Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine news :1.
LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing2.
LifeCare Holdings, Inc. Announces Third Quarter Results3.
Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources4.
Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market5.
Solera Holdings, Inc. Appoints Jason Brady as General Counsel6.
Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results7.
Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.8.
Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry9.
NightHawk Radiology Holdings, Inc. Announces Board Member Departure10.
NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 200811.
Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds